Male Fertility Potential Alteration in Rheumatic Diseases: a Systematic Review

Overview

Journal Int Braz J Urol

Specialty Urology

Date 2016 Apr 28

PMID 27120778

Citations 20

Authors

Bruno Camargo Tiseo

Marcello Cocuzza

Eloisa Bonfa

Miguel Srougi

Clovis A Silva

Affiliations

Soon will be listed here.

Abstract

Background: Improved targeted therapies for rheumatic diseases were developed recently resulting in a better prognosis for affected patients. Nowadays, patients are living longer and with improved quality of life, including fertility potential. These patients are affected by impaired reproductive function and the causes are often multifactorial related to particularities of each disease. This review highlights how rheumatic diseases and their management affect testicular function and male fertility.

Materials And Methods: A systematic review of literature of all published data after 1970 was conducted. Data was collected about fertility abnormalities in male patients with systemic lupus erythematosus, rheumatoid arthritis, dermatomyositis, ankylosing spondylitis, Behçet disease and gout. Two independent researchers carried out the search in online databases.

Results: A total of 19 articles were included addressing the following diseases: 7 systemic lupus erythematosus, 6 Behçet disease, 4 ankylosing spondylitis, 2 rheumatoid arthritis, 2 dermatomyositis and one gout. Systemic lupus erythematosus clearly affects gonadal function impairing spermatogenesis mainly due to antisperm antibodies and cyclophosphamide therapy. Behçet disease, gout and ankylosing spondylitis patients, including those under anti-TNF therapy in the latter disease, do not seem to have reduced fertility whereas in dermatomyositis, the fertility potential is hampered by disease activity and by alkylating agents. Data regarding rheumatoid arthritis is scarce, gonadal dysfunction observed as consequence of disease activity and antisperm antibodies.

Conclusions: Reduced fertility potential is not uncommon. Its frequency and severity vary among the different rheumatic diseases. Permanent infertility is rare and often associated with alkylating agent therapy.

Citing Articles

Testicular immunity.

Li S, Kumar S, Gu X, DeFalco T Mol Aspects Med. 2024; 100:101323.

PMID: 39591799 PMC: 11624985. DOI: 10.1016/j.mam.2024.101323.

Risk Assessment and Optimization for Pregnancy in Patients with Rheumatic Diseases.

Kwok A Diagnostics (Basel). 2024; 14(13).

PMID: 39001304 PMC: 11241172. DOI: 10.3390/diagnostics14131414.

Male patients with inflammatory joint diseases are less likely than controls to be childless: results from a Norwegian population-based cohort study of 10 865 patients.

Sigmo G, Hauge S, Hufthammer K, Wallenius M, Salvesen K, Daltveit A Ann Rheum Dis. 2024; 83(4):457-463.

PMID: 38262688 PMC: 10958328. DOI: 10.1136/ard-2023-224998.

Diverse selection pressures shaping the genetic architecture of behçet disease susceptibility.

Sezgin E, Kaplan E Front Genet. 2022; 13:983646.

PMID: 36246630 PMC: 9561091. DOI: 10.3389/fgene.2022.983646.

MANTA and MANTA-RAy: Rationale and Design of Trials Evaluating Effects of Filgotinib on Semen Parameters in Patients with Inflammatory Diseases.

Hellstrom W, Dolhain R, Ritter T, Watkins T, Arterburn S, Dekkers G Adv Ther. 2022; 39(7):3403-3422.

PMID: 35614292 PMC: 9239965. DOI: 10.1007/s12325-022-02168-4.

References

Fukutani K, Ishida H, Shinohara M, Minowada S, Niijima T, Hijikata K . Suppression of spermatogenesis in patients with Behçet's disease treated with cyclophosphamide and colchicine. Fertil Steril. 1981; 36(1):76-80. DOI: 10.1016/s0015-0282(16)45622-0. View

Latta K, von Schnakenburg C, Ehrich J . A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol. 2001; 16(3):271-82. DOI: 10.1007/s004670000523. View

Fu L, Xiong D, Ding X, Li C, Zhang L, Ding M . Genetic screening for chromosomal abnormalities and Y chromosome microdeletions in Chinese infertile men. J Assist Reprod Genet. 2012; 29(6):521-7. PMC: 3370047. DOI: 10.1007/s10815-012-9741-y. View

Vilarinho S, Costallat L . Evaluation of the hypothalamic-pituitary-gonadal axis in males with systemic lupus erythematosus. J Rheumatol. 1998; 25(6):1097-103. View

Shiraishi Y, Shibahara H, Koriyama J, Hirano Y, Okazaki H, Minota S . Incidence of antisperm antibodies in males with systemic autoimmune diseases. Am J Reprod Immunol. 2009; 61(3):183-9. DOI: 10.1111/j.1600-0897.2008.00676.x. View

Rival C, Guazzone V, Theas M, Lustig L . Pathomechanism of autoimmune orchitis. Andrologia. 2005; 37(6):226-7. DOI: 10.1111/j.1439-0272.2005.00695.x. View

Yu T . The efficacy of colchicine prophylaxis in articular gout--a reappraisal after 20 years. Semin Arthritis Rheum. 1982; 12(2):256-64. DOI: 10.1016/0049-0172(82)90065-8. View

Romeo C, Ientile R, Santoro G, Impellizzeri P, Turiaco N, Impala P . Nitric oxide production is increased in the spermatic veins of adolescents with left idiophatic varicocele. J Pediatr Surg. 2001; 36(2):389-93. DOI: 10.1053/jpsu.2001.20724. View

Arap M, Vicentini F, Cocuzza M, Hallak J, Athayde K, Lucon A . Late hormonal levels, semen parameters, and presence of antisperm antibodies in patients treated for testicular torsion. J Androl. 2007; 28(4):528-32. DOI: 10.2164/jandrol.106.002097. View

10.

Cocuzza M, Sikka S, Athayde K, Agarwal A . Clinical relevance of oxidative stress and sperm chromatin damage in male infertility: an evidence based analysis. Int Braz J Urol. 2007; 33(5):603-21. DOI: 10.1590/s1677-55382007000500002. View

11.

Silva C, Hallak J, Pasqualotto F, Barba M, Saito M, Kiss M . Gonadal function in male adolescents and young males with juvenile onset systemic lupus erythematosus. J Rheumatol. 2002; 29(9):2000-5. View

12.

Gordon D, Beastall G, Thomson J, Sturrock R . Androgenic status and sexual function in males with rheumatoid arthritis and ankylosing spondylitis. Q J Med. 1986; 60(231):671-9. View

13.

Nallella K, Sharma R, Aziz N, Agarwal A . Significance of sperm characteristics in the evaluation of male infertility. Fertil Steril. 2006; 85(3):629-34. DOI: 10.1016/j.fertnstert.2005.08.024. View

14.

Marshburn P, Kutteh W . The role of antisperm antibodies in infertility. Fertil Steril. 1994; 61(5):799-811. DOI: 10.1016/s0015-0282(16)56687-4. View

15.

Tabbara K . Chlorambucil in Behçet's disease. A reappraisal. Ophthalmology. 1983; 90(8):906-8. DOI: 10.1016/s0161-6420(83)80014-1. View

16.

Miller M, Urowitz M, Gladman D, Killinger D . Systemic lupus erythematosus in males. Medicine (Baltimore). 1983; 62(5):327-34. DOI: 10.1097/00005792-198309000-00005. View

17.

Hersh A, von Scheven E, Yelin E . Adult outcomes of childhood-onset rheumatic diseases. Nat Rev Rheumatol. 2011; 7(5):290-5. PMC: 3705738. DOI: 10.1038/nrrheum.2011.38. View

18.

Martinez Lopez J, Loza E, Carmona L . Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding). Clin Exp Rheumatol. 2009; 27(4):678-84. View

19.

Mizushima Y, Matsumura N, Mori M, Shimizu T, Fukushima B, Mimura Y . Colchicine in Behçet's disease. Lancet. 1977; 2(8046):1037. DOI: 10.1016/s0140-6736(77)92945-2. View

20.

Moraes A, Bonfa E, Cocuzza M, Borges C, Saito O, Silva C . Gonad evaluation in male dermatomyositis. A pilot study. Clin Exp Rheumatol. 2010; 28(3):441-2. View